chrpositiondbsnpidfoundwho (max 10)freqhomozygouseffectdescription
chr125303329rs121912763 G30%yesPathogenicRhd,_weak_d,_type_I
chr1198807802rs9660525 G1338%yesPathogenicAcute_myeloid_leukemia_with_maturation
chr1198826991rs12406470 G1749%yesPathogenicAcute_myeloid_leukemia_with_maturation
chr1198898549rs60639710 G2172%yesPathogenicAcute_myeloid_leukemia_with_maturation
chr1198898955rs10800597 G2172%yesPathogenicAcute_myeloid_leukemia_with_maturation
chr1198900385rs10800598 G2274%yesPathogenicAcute_myeloid_leukemia_with_maturation
chr3124055231rs9289231 G314%PathogenicCoronary_heart_disease_5
chr499318162rs1229984 G3194%yesprotectiveAlcohol_dependence
chr499339632rs698 G1735%protectiveAlcohol_dependence
chr499342808rs1693482 G1734%protectiveAlcohol_dependence
chr66320575rs2815822 G3088%yesPathogenicFactor_XIII,_A_subunit,_deficiency_of
chr7128938247rs2004640 G21yesPathogenic,_risk_factorRheumatoid_arthritis
chr922003368rs1063192 G2469%yesprotectiveThree_Vessel_Coronary_Disease
chr922072302rs9632884 G1661%yesprotectiveThree_Vessel_Coronary_Disease
chr922103814rs1333042 G1661%yesprotectiveThree_Vessel_Coronary_Disease
chr106080046rs11594656 G1317%PathogenicDiabetes_mellitus,_insulin-dependent,_10
chr11116820918rs5110 G55%PathogenicAPOLIPOPROTEIN_A-IV_POLYMORPHISM,_APOA4*1/APOA4*2
chr1627344882rs1805010 G2645%Pathogenic,_protectiveAcquired_immunodeficiency_syndrome,_slow_progression_to
chr1758281401rs2333227 G1223%protective,_risk_factorAlzheimer_disease,_susceptibility_to
indel:
chr2201232808rs3834129 G2748%protectiveLung_cancer,_protection_against
chr11637536rs587776842 G0
1%PathogenicAutonomic_nervous_system_dysfunction
chr1730237266rs774676466 G1022%PathogenicSerotonin_transporter_activity,_increased/decreased
chr1945353295rs587778271 G20%Pathogenic/Likely_pathogenicMetachromatic_leukodystrophy_variant